Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

European Research Council grant · Running

iChatRD iChatRD: A user-centred clinical decision support system for the diagnosis of rare and inherited metabolic diseases

Coordinator
University of Galway, Ireland
Runs
1 September 2026 to 29 February 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101335281

What the project is doing

In the project's own words, from its summary on CORDIS.

Rare diseases, including inherited metabolic diseases (IMDs), affect ~5% of the global population, yet diagnosis often takes years, causing preventable morbidity. Many computational tools are either limited to structured phenotype inputs or operate as “black boxes” prone to errors. Within the ERC project, Avatar, we have developed ChatRD, an AI-assisted, fully transparent clinical decision support tool that suggests expert-level rare disease diagnoses from unstructured patient descriptions within seconds.

However, ChatRD’s interactive web interface has been developed without stakeholder feedback, a requirement for suitability in daily clinical routine and end-user trust. Consequently, the overall goal of this project is to translate the current research prototype into a practical, clinically relevant tool, which is also aligned with regulatory requirements and market needs. We will achieve this by first gathering, synthesising, and prioritising end-user feedback through a structured engagement strategy across three tiers: direct involvement of expert clinicians, broader clinical engagement through interactive in-person workshops, and large-scale online consultations.

We will focus on system usability, content relevance, user interaction, and healthcare workflow integration. Iterative refinements will be guided by ranked stakeholder priorities. Finally, we will prepare for post-PoC deployment by validating the resulting ChatRD2.0, through additional stakeholder review and consolidating a roadmap for clinical readiness, scaling, and technology valorisation. The work will be carried out by a highly experienced team combining clinical, technical, and translational expertise.

This PoC will de-risk future deployment by demonstrating real-world usability and relevance, with potential to significantly shorten diagnostic timelines for rare disease and IMD patients and reduce healthcare system burden.

Who is involved

OrganisationCityCountryRole
University of GalwayGalwayIrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI